132 related articles for article (PubMed ID: 21534556)
1. Structural basis for the β-adrenergic receptor subtype selectivity of the representative agonists and antagonists.
Roy KK; Saxena AK
J Chem Inf Model; 2011 Jun; 51(6):1405-22. PubMed ID: 21534556
[TBL] [Abstract][Full Text] [Related]
2. Structural and conformational features determining selective signal transduction in the beta 3-adrenergic receptor.
Blin N; Camoin L; Maigret B; Strosberg AD
Mol Pharmacol; 1993 Dec; 44(6):1094-104. PubMed ID: 7903415
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for ligand binding and specificity in adrenergic receptors: implications for GPCR-targeted drug discovery.
Huber T; Menon S; Sakmar TP
Biochemistry; 2008 Oct; 47(42):11013-23. PubMed ID: 18821775
[TBL] [Abstract][Full Text] [Related]
4. Determination of structural domains for G protein coupling and ligand binding in beta 3-adrenergic receptor.
Guan XM; Amend A; Strader CD
Mol Pharmacol; 1995 Sep; 48(3):492-8. PubMed ID: 7565630
[TBL] [Abstract][Full Text] [Related]
5. Identification of critical extracellular loop residues involved in alpha 1-adrenergic receptor subtype-selective antagonist binding.
Zhao MM; Hwa J; Perez DM
Mol Pharmacol; 1996 Nov; 50(5):1118-26. PubMed ID: 8913343
[TBL] [Abstract][Full Text] [Related]
6. Structure of β-adrenergic receptors.
Brueckner F; Piscitelli CL; Tsai CJ; Standfuss J; Deupi X; Schertler GF
Methods Enzymol; 2013; 520():117-51. PubMed ID: 23332698
[TBL] [Abstract][Full Text] [Related]
7. Structural insights into agonist-induced activation of G-protein-coupled receptors.
Deupi X; Standfuss J
Curr Opin Struct Biol; 2011 Aug; 21(4):541-51. PubMed ID: 21723721
[TBL] [Abstract][Full Text] [Related]
8. Binding pockets of the beta(1)- and beta(2)-adrenergic receptors for subtype-selective agonists.
Isogaya M; Sugimoto Y; Tanimura R; Tanaka R; Kikkawa H; Nagao T; Kurose H
Mol Pharmacol; 1999 Nov; 56(5):875-85. PubMed ID: 10531390
[TBL] [Abstract][Full Text] [Related]
9. Three-dimensional models for beta-adrenergic receptor complexes with agonists and antagonists.
Furse KE; Lybrand TP
J Med Chem; 2003 Oct; 46(21):4450-62. PubMed ID: 14521408
[TBL] [Abstract][Full Text] [Related]
10. Towards a thermodynamic definition of efficacy in partial agonism: The thermodynamics of efficacy and ligand proton transfer in a G protein-coupled receptor of the rhodopsin class.
Broadley KJ; Sykes SC; Davies RH
Biochem Pharmacol; 2010 Nov; 80(10):1537-45. PubMed ID: 20727346
[TBL] [Abstract][Full Text] [Related]
11. Thermodynamic properties of agonist interactions with the beta adrenergic receptor-coupled adenylate cyclase system. I. High- and low-affinity states of agonist binding to membrane-bound beta adrenergic receptors.
Contreras ML; Wolfe BB; Molinoff PB
J Pharmacol Exp Ther; 1986 Apr; 237(1):154-64. PubMed ID: 2870174
[TBL] [Abstract][Full Text] [Related]
12. Agonist interactions with chimeric and mutant beta1- and beta3-adrenergic receptors: involvement of the seventh transmembrane region in conferring subtype specificity.
Granneman JG; Lahners KN; Zhai Y
Mol Pharmacol; 1998 May; 53(5):856-61. PubMed ID: 9584211
[TBL] [Abstract][Full Text] [Related]
13. Interactions of agonists and antagonists with beta-adrenergic receptors.
Molinoff PB; Weiland GA; Heidenreich KA; Pittman RN; Minneman KP
Adv Cyclic Nucleotide Res; 1981; 14():51-67. PubMed ID: 6116391
[TBL] [Abstract][Full Text] [Related]
14. Molecular dynamics simulations reveal insights into key structural elements of adenosine receptors.
Rodríguez D; Piñeiro Á; Gutiérrez-de-Terán H
Biochemistry; 2011 May; 50(19):4194-208. PubMed ID: 21480628
[TBL] [Abstract][Full Text] [Related]
15. Agonist-induced conformational changes in bovine rhodopsin: insight into activation of G-protein-coupled receptors.
Bhattacharya S; Hall SE; Vaidehi N
J Mol Biol; 2008 Oct; 382(2):539-55. PubMed ID: 18638482
[TBL] [Abstract][Full Text] [Related]
16. Phenylalanine in the second membrane-spanning domain of alpha 1A-adrenergic receptor determines subtype selectivity of dihydropyridine antagonists.
Hamaguchi N; True TA; Saussy DL; Jeffs PW
Biochemistry; 1996 Nov; 35(45):14312-7. PubMed ID: 8916917
[TBL] [Abstract][Full Text] [Related]
17. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
[TBL] [Abstract][Full Text] [Related]
18. A model of the adrenergic beta-2 receptor and binding sites for agonist and antagonist.
Lewell XQ
Drug Des Discov; 1992; 9(1):29-48. PubMed ID: 1360841
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in structure, binding sites with ligands and pharmacological function of beta-adrenoceptors obtained by molecular biology and molecular modeling.
Nagatomo T; Koike K
Life Sci; 2000; 66(25):2419-26. PubMed ID: 10894084
[TBL] [Abstract][Full Text] [Related]
20. Beta 1- and beta 2-adrenergic receptors display subtype-selective coupling to Gs.
Green SA; Holt BD; Liggett SB
Mol Pharmacol; 1992 May; 41(5):889-93. PubMed ID: 1350321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
